Altered growth of human colon cancer cell lines disrupted at activated Ki-ras
- PMID: 8465203
- DOI: 10.1126/science.8465203
Altered growth of human colon cancer cell lines disrupted at activated Ki-ras
Abstract
Point mutations that activate the Ki-ras proto-oncogene are presented in about 50 percent of human colorectal tumors. To study the functional significance of these mutations, the activated Ki-ras genes in two human colon carcinoma cell lines, DLD-1 and HCT 116, were disrupted by homologous recombination. Compared with parental cells, cells disrupted at the activated Ki-ras gene were morphologically altered, lost the capacity for anchorage-independent growth, grew more slowly both in vitro and in nude mice, and showed reduced expression of c-myc. Thus, the activated Ki-ras gene plays a key role in colorectal tumorigenesis through altered cell differentiation and cell growth.
Similar articles
-
[Analysis of molecular mechanism in colorectal tumorigenesis].Fukuoka Igaku Zasshi. 1993 Jan;84(1):25-35. Fukuoka Igaku Zasshi. 1993. PMID: 8458595 Japanese.
-
Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells.Cancer Res. 2000 Dec 15;60(24):6886-9. Cancer Res. 2000. PMID: 11156386
-
Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.Cancer Res. 1999 May 15;59(10):2445-50. Cancer Res. 1999. PMID: 10344756
-
K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.Cancer Res. 2000 Dec 1;60(23):6750-6. Cancer Res. 2000. PMID: 11118062
-
Ki-ras activation and expression in transformed mouse lung cell lines.Mol Carcinog. 1990;3(5):279-86. doi: 10.1002/mc.2940030508. Mol Carcinog. 1990. PMID: 2244960
Cited by
-
Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.Cancer Res. 2013 Jun 1;73(11):3248-61. doi: 10.1158/0008-5472.CAN-12-1578. Epub 2013 Apr 11. Cancer Res. 2013. PMID: 23580570 Free PMC article.
-
Eradication of pathogenic beta-catenin by Skp1/Cullin/F box ubiquitination machinery.Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12729-34. doi: 10.1073/pnas.2133261100. Epub 2003 Oct 16. Proc Natl Acad Sci U S A. 2003. PMID: 14563921 Free PMC article.
-
Proteomic Mapping of the Interactome of KRAS Mutants Identifies New Features of RAS Signalling Networks and the Mechanism of Action of Sotorasib.Cancers (Basel). 2023 Aug 17;15(16):4141. doi: 10.3390/cancers15164141. Cancers (Basel). 2023. PMID: 37627169 Free PMC article.
-
Farnesyltransferase inhibitors and anti-Ras therapy.Breast Cancer Res Treat. 1996;38(1):75-83. doi: 10.1007/BF01803786. Breast Cancer Res Treat. 1996. PMID: 8825125 Review.
-
BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells.Oncotarget. 2016 Feb 23;7(8):9188-221. doi: 10.18632/oncotarget.6942. Oncotarget. 2016. PMID: 26802026 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous